跳至主要内容
临床试验/NCT04718922
NCT04718922已完成4 期

Effect of Chlorhexidine Mouthrinse on Prevention of Microbial Contamination During EBUS-TBNA: a Randomized Clinical Trial

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2021年1月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
112
试验地点
1
主要终点
Colony forming unit (CFU) counts of EBUS-TBNA needle wash solution in aerobic media

研究概览

简要总结

The purpose of this study is to investigate whether chlorhexidine mouthrinse is effective in preventing microbial contamination during endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA).

详细描述

EBUS-TBNA using the convex probe is a standard of care for the assessment of mediastinal and hilar lymphadenopathy. Although EBUS-TBNA is a minimally invasive procedure, rare but serious infectious complications such as pneumonia, lung abscess, empyema, mediastinal adenitis/abscess, mediastinitis, pericarditis, and sepsis were reported. EBUS-scope might be contaminated with oropharyngeal commensal bacteria while passing the oropharyngeal airway during EBUS-TBNA. Contamination of punctured lymph nodes by oropharyngeal commensal bacteria can cause severe infections.

Chlorhexidine gluconate is an antimicrobial agent that has a broad antibacterial activity including both gram-positive and negative bacteria. Chlorhexidine has been widely used for surgical scrub, skin disinfection, and mouthrinse. We, therefore, designed a phase 4, single-center, randomized, controlled clinical trial to investigate whether chlorhexidine mouthrinse is effective in preventing microbial contamination during EBUS-TBNA.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • inpatients aged 19 years and older who are scheduled to undergo EBUS-TBNA using a convex probe

排除标准

  • antiseptic mouthrinse within 7 days before inclusion;
  • active infection or antibiotic treatment within 7 days before inclusion;
  • immunocompromised;
  • trachemostomy status;
  • who have already undergone gastroscopy on the same day when EBUS- TBNA is scheduled to be administered

研究组 & 干预措施

Experimental Arm

Experimental

Mouthrinse with 100 ml 0.12% chlorhexidine for 1 min

干预措施: Chlorhexidine Gluconate 0.12 % Mouthwash (Drug)

结局指标

主要结局

Colony forming unit (CFU) counts of EBUS-TBNA needle wash solution in aerobic media

时间窗: Needle wash solution is obtained immediately after termination of EBUS-TBNA

Needle wash solution is obtained by instilling 5mL of sterile physiological saline into the puncture needle.

次要结局

  • CFU counts of EBUS-TBNA needle wash solution in anaerobic media(Needle wash solution is obtained immediately after termination of EBUS-TBNA)
  • Fever(24 hours after EBUS-TBNA)
  • Infectious complications(4 weeks after EBUS-TBNA)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jaeyoung Cho

Assistant Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验

Chlorhexidine Mouthrinse Before EBUS-TBNA | 临床试验